Psoriasis
Psoriasis is a chronic autoimmune condition that causes rapid skin cell production, leading to thick, scaly patches on the skin. It occurs when the immune system mistakenly attacks healthy skin cells, triggering inflammation and excessive cell turnover. Psoriasis is associated with increased risk of psoriatic arthritis, cardiovascular disease, and other comorbidities.
Prevalence
Psoriasis affects approximately 7.5 million Americans and 2-3% of the global population. About 30% of people with psoriasis develop psoriatic arthritis.
Who It Affects
Can develop at any age but most commonly appears between ages 15-35 and again between 50-60. Family history significantly increases risk. Affects men and women equally.
Important: This information is for educational purposes only and does not constitute medical advice. Regenerative therapies are investigational and not FDA-approved to treat this condition.
Common Symptoms
Common Causes & Risk Factors
Traditional Treatment Options
Topical Treatments
Corticosteroid creams, vitamin D analogues, retinoids, and calcineurin inhibitors.
Limitations: May be insufficient for widespread disease. Long-term steroid use causes skin thinning.
Phototherapy
UV light treatment to slow skin cell turnover.
Limitations: Requires regular office visits. Increases skin cancer risk with long-term use.
Systemic Medications
Methotrexate, cyclosporine, or acitretin for moderate to severe psoriasis.
Limitations: Significant side effects requiring monitoring (liver, kidney, blood). Not suitable for long-term use in some cases.
Biologic Therapies
Targeted therapies (TNF, IL-17, IL-23 inhibitors) that have revolutionized severe psoriasis treatment.
Limitations: Expensive. Increased infection risk. Some patients don't respond or lose response.
Regenerative Medicine Approach
How Regenerative Therapy May Help
Regenerative medicine for psoriasis is being explored for potential immunomodulatory effects that may help regulate the overactive immune response driving skin inflammation. Research is preliminary, and current biologic therapies are highly effective for many patients.
Potential Benefits Being Studied:
- Being studied for potential immunomodulatory effects
- May help modulate T-cell activity (under investigation)
- Research exploring effects on skin inflammation
- MSCs have anti-inflammatory properties being studied
- May be considered when standard therapies fail
- Does not replace proven psoriasis treatments
Biologics Used:
Mesenchymal stem cells in early research
Exosomes being studied for immunomodulatory potential
Frequently Asked Questions
Why consider this when biologics work well?
For most patients with moderate to severe psoriasis, current biologics are highly effective. Regenerative therapy research is very preliminary for psoriasis and would only be considered if standard treatments have failed.
Can this help psoriatic arthritis?
Psoriatic arthritis requires systemic treatment to prevent joint damage. There is limited research on regenerative therapy for PsA. Continue working with your rheumatologist on proven disease-modifying treatments.
Is research promising for psoriasis?
Research is early-stage. Given the excellent efficacy of current biologic therapies for psoriasis, regenerative approaches are not a priority compared to conditions with fewer treatment options.
Ready to Explore Your Options?
Schedule a free consultation to discuss psoriasis and learn if regenerative medicine may be right for you.
Important Disclaimer
Regenerative therapies for psoriasis are investigational and not FDA-approved. Proven, effective treatments exist for psoriasis. Consult a dermatologist for evidence-based management.